Abstract
A class of cationic clays, montmorillonite (MMT) is a bio-inspired layered material possessing high internal surface area and high adsorption ability. MMT has attracted much attention as an oral delivery carrier, because it provides mucoadhesive property, which is a fascinating feature to across the gastrointestinal barrier. Furthermore, cationic drugs or bioactive molecules can be intercalated into the interlayer spaces by electrostatic interaction due to its good swelling property and high cation exchange capacity (CEC). However, a few researches on the toxicity of MMT were reported, although many attempts have been made to develop MMT as a delivery carrier for small bioactive molecules. In this study, we evaluated the cytotoxicity of MMT by measuring cell proliferation in short- and long-terms, membrane integrity, and oxidative stress. Moreover, the acute oral toxicity and pharmacokinetic studies of MMT were also carried out to determine the lethal dose 50% (LD50) values and to elucidate their possible accumulation in the target specific tissues or elimination from the body, respectively, after oral administration. The results demonstrated that MMT could cause some cytotoxic effects at high concentration after long-time exposure, while any remarkable toxicity was not found in mice receiving up to the highest dose tested, 1,000 mg/kg. MMT could be absorbed into the body within 2 h, but it did not significantly accumulate in any specific organ. These findings will provide critical information about the potential toxicity of MMT, finally contributing to its sustainable development as an oral delivery carrier with safe level.
Similar content being viewed by others
References
Swartzen-Allen, S. L. & Matijevic, E. Surface and colloid chemistry of clays. Chem Revs 74:74385–74400 (1974).
Tomas, F. et al. Layer charge and eletrophoretic mobility of smectites. Colloids Surf 159:351–358 (1999).
Lee, W. F. & Fu, Y. T. Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. Appl Polym Scl 89:3652–3660 (2003).
Komine, H. Simplified evaluation for swelling characteristics of bentonites. Eng Geol 71:256–279 (2004).
Aguzzi, C. C., Cerezo, P., Viseras, C. & Caramella, C. Use of clays as drug delivery systems: Possibilities and limitations. Appl Clay Sci 36:22–36 (2007).
Ramos, A. J. & Hernández, E. In vitro aflatoxin adsorption by means of a montmorillonite silicate. A study of adsorption isotherms. Anim Feed Sci Technol 62: 263–269 (1996).
Zheng, J. P., Luan, L., Wang, H. Y., Xi, L. F. & Yao, K. D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci 36: 297–301 (2007).
Fudala, A. A., Pálinkó, I. & Kiricsi, I. Preparation and characterization of hybrid organic-inorganic composite materials using the amphoteric property of amino acids: amino acid intercalated layered double hydroxide and montmorillonite. Inorg Chem 38:4653–4658 (1999).
Kollár, T., Pálinkó, I., Kónya, Z. & Kiricsi, I. Intercalating amino acid guests into montmorillonite host. J Mol Struct 651–653:335–340 (2003).
Jin, F. H. et al. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23:1981–1987 (2002).
Park, J. K. et al. Controlled release of donepezil intercalated in smectite clays. Int J Pharm 359:198–204 (2008).
Jung, H., Kim, H. M., Choy, Y. B., Hwang, S. J. & Choy, J. H. Itraconazole-Laponite: Kinetics and mechanism of drug release. Appl Clay Sci 40:99–107 (2008).
Jung, H., Kim, H. M., Choy, Y. B., Hwang, S. J. & Choy, J. H. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconzaole. Int J Pharm 349:283–290 (2008).
Yu, J., Baek, M., Chung, H. E. & Choi, S. J. Physicochemical properties affecting the potential in vitro cytotoxicity of inorganic layered nanoparticles. Toxicol Environ Health Sci 2:149–152 (2010).
Murphy, E. J., Roberts, E. & Horrocks, L. A. Aluminum silicate toxicity in cell cultures. Neuroscience 55:597–605 (1993).
Lee, Y. H. et al. Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model. Biomed Eng Appl Basis Comm 17:12–18 (2005).
Herzog, E. et al. A new approach to the toxicity testing of carbon-based nanomaterials-The clonogenic assay. Toxicol Lett 174:49–60 (2007).
Baek, M. et al. Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge. J Phys Conf Ser 304:1–7 (2011).
kallifatidis, G. et al. Sulforaphane increases drug-modiated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 19:188–195 (2011).
Lliescu, R. I., Andronescu, E., Voicu, G., Ficai, A. & Covaliu, C. I. Hybrid materials based on montmorillonite and citostatic drugs: Preparation and charctrization. Appl Clay Sci 52:62–68 (2011).
Dong, Y. & Feng, S. S. Poly (D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:6068–6076 (2005).
Lambert, J. D., Sang, S., Hong, J. & Yang, C. S. Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (−)-epigallocatechin-3-gallate. J Agric Food Chem 58:10016–10019 (2010)
Chung, H. E., Kim, I. S., Baek, M., Yu, J. & Choi, S. J. Long-term cytotoxicity potential of anionic nanoclays in human cells. Toxicol Environ Health Sci 3:129–133 (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baek, M., Lee, JA. & Choi, SJ. Toxicological effects of a cationic clay, montmorillonite in vitro and in vivo . Mol. Cell. Toxicol. 8, 95–101 (2012). https://doi.org/10.1007/s13273-012-0012-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-012-0012-x